BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Pierro F, Iqtadar S, Khan A, Ullah Mumtaz S, Masud Chaudhry M, Bertuccioli A, Derosa G, Maffioli P, Togni S, Riva A, Allegrini P, Khan S. Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial. Int J Gen Med 2021;14:2807-16. [PMID: 34194240 DOI: 10.2147/IJGM.S318949] [Cited by in F6Publishing: 42] [Reference Citation Analysis]
Number Citing Articles
1 Chaves OA, Lima CR, Fintelman-rodrigues N, Sacramento CQ, de Freitas CS, Vazquez L, Temerozo JR, Rocha ME, Dias SS, Carels N, Bozza PT, Castro-faria-neto HC, Souza TML. Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases. International Journal of Biological Macromolecules 2022;222:1015-26. [DOI: 10.1016/j.ijbiomac.2022.09.204] [Reference Citation Analysis]
2 Duhalde Vega M, Olivera D, Gastão Davanzo G, Bertullo M, Noya V, Fabiano de Souza G, Primon Muraro S, Castro I, Arévalo AP, Crispo M, Galliussi G, Russo S, Charbonnier D, Rammauro F, Jeldres M, Alamón C, Varela V, Batthyany C, Bollati-Fogolín M, Oppezzo P, Pritsch O, Proença-Módena JL, Nakaya HI, Trias E, Barbeito L, Anegon I, Cuturi MC, Moraes-Vieira P, Segovia M, Hill M. PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease. Sci Adv 2022;8:eabn6545. [PMID: 36129987 DOI: 10.1126/sciadv.abn6545] [Reference Citation Analysis]
3 Khan MM, Goh YW, Ahmad N, Siddique MM. Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2. Bioprocess Biosyst Eng 2022. [PMID: 36125525 DOI: 10.1007/s00449-022-02788-8] [Reference Citation Analysis]
4 Catalano A, Iacopetta D, Ceramella J, Maio AC, Basile G, Giuzio F, Bonomo MG, Aquaro S, Walsh TJ, Sinicropi MS, Saturnino C, Geronikaki A, Salzano G. Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment? Foods 2022;11:2884. [PMID: 36141012 DOI: 10.3390/foods11182884] [Reference Citation Analysis]
5 Mohammadi M, Yahyapour Y, Nasrollahian S, Tayefeh-arbab MH, Javanian M, Rajabi Fadardi M, Mousavi Kani SN, Honarvar Bakeshloo P, Saghebi R, Rajabnia M, Halaji M, Pournajaf A. A Review on Herbal Secondary Metabolites Against COVID-19 Focusing on the Genetic Variants of SARS-CoV-2. Jundishapur J Nat Pharm Prod 2022;In Press. [DOI: 10.5812/jjnpp-129618] [Reference Citation Analysis]
6 Schmitt CA, Wang B, Demaria M. Senescence and cancer - role and therapeutic opportunities. Nat Rev Clin Oncol 2022. [PMID: 36045302 DOI: 10.1038/s41571-022-00668-4] [Reference Citation Analysis]
7 Miclea I. Secondary Metabolites with Biomedical Applications from Plants of the Sarraceniaceae Family. IJMS 2022;23:9877. [DOI: 10.3390/ijms23179877] [Reference Citation Analysis]
8 Notarbartolo V, Montante C, Ferrante G, Giuffrè M. Antioxidant Effects of Dietary Supplements on Adult COVID-19 Patients: Why Do We Not Also Use Them in Children? Antioxidants 2022;11:1638. [DOI: 10.3390/antiox11091638] [Reference Citation Analysis]
9 Zaytseva Y, Petruk A, Novikova T. Thidiazuron and LED Lighting Enhance Taxifolin and Rutin Production in Rhododendron mucronulatum Turcz. Microshoot Culture. J Plant Growth Regul. [DOI: 10.1007/s00344-022-10757-4] [Reference Citation Analysis]
10 Yip KM, Lee KM, Ng TB, Xu S, Yung KKL, Qu S, Cheung AKL, Sze SCW. An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding. Chin Med 2022;17:88. [PMID: 35897044 DOI: 10.1186/s13020-022-00635-2] [Reference Citation Analysis]
11 Panfoli I, Esposito A. Beneficial effect of polyphenols in COVID-19 and the ectopic F1 FO -ATP synthase: Is there a link? J Cell Biochem 2022. [PMID: 35838055 DOI: 10.1002/jcb.30306] [Reference Citation Analysis]
12 Denholm M, Rintoul RC, Muñoz-Espín D. SARS-CoV-2-induced senescence as a potential therapeutic target. Eur Respir J 2022:2201101. [PMID: 35777777 DOI: 10.1183/13993003.01101-2022] [Reference Citation Analysis]
13 Al-Kuraishy HM, Al-Gareeb AI, Kaushik A, Kujawska M, Batiha GE. Ginkgo biloba in the management of the COVID-19 severity. Arch Pharm (Weinheim) 2022;:e2200188. [PMID: 35672257 DOI: 10.1002/ardp.202200188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Khan A, Iqtadar S, Mumtaz SU, Heinrich M, Pascual-figal DA, Livingstone S, Abaidullah S. Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial. Front Pharmacol 2022;13:898062. [DOI: 10.3389/fphar.2022.898062] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhang L, Ma J, Yang F, Li S, Ma W, Chang X, Yang L. Neuroprotective Effects of Quercetin on Ischemic Stroke: A Literature Review. Front Pharmacol 2022;13:854249. [PMID: 35662707 DOI: 10.3389/fphar.2022.854249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Imran M, Thabet HK, Alaqel SI, Alzahrani AR, Abida A, Alshammari MK, Kamal M, Diwan A, Asdaq SMB, Alshehri S. The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature. Antioxidants 2022;11:876. [DOI: 10.3390/antiox11050876] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
17 Nguyen TLA, Bhattacharya D. Antimicrobial Activity of Quercetin: An Approach to Its Mechanistic Principle. Molecules 2022;27:2494. [DOI: 10.3390/molecules27082494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Pawar A, Russo M, Rani I, Goswami K, Russo GL, Pal A. A critical evaluation of risk to reward ratio of quercetin supplementation for COVID-19 and associated comorbid conditions. Phytother Res 2022. [PMID: 35393674 DOI: 10.1002/ptr.7461] [Reference Citation Analysis]
19 Alizadeh SR, Ebrahimzadeh MA. O-substituted quercetin derivatives: Structural classification, drug design, development, and biological activities, a review. Journal of Molecular Structure 2022;1254:132392. [DOI: 10.1016/j.molstruc.2022.132392] [Reference Citation Analysis]
20 Yusuf AP, Zhang J, Li J, Muhammad A, Abubakar MB. Herbal medications and natural products for patients with covid-19 and diabetes mellitus: potentials and challenges. Phytomedicine Plus 2022. [DOI: 10.1016/j.phyplu.2022.100280] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Osorio C, Sfera A, Anton JJ, Thomas KG, Andronescu CV, Li E, Yahia RW, Avalos AG, Kozlakidis Z. Virus-Induced Membrane Fusion in Neurodegenerative Disorders. Front Cell Infect Microbiol 2022;12:845580. [DOI: 10.3389/fcimb.2022.845580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Mbikay M, Chrétien M. Isoquercetin as an Anti-Covid-19 Medication: A Potential to Realize. Front Pharmacol 2022;13:830205. [PMID: 35308240 DOI: 10.3389/fphar.2022.830205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Yao J, Zhang Y, Wang XZ, Zhao J, Yang ZJ, Lin YP, Sun L, Lu QY, Fan GJ. Flavonoids for Treating Viral Acute Respiratory Tract Infections: A Systematic Review and Meta-Analysis of 30 Randomized Controlled Trials. Front Public Health 2022;10:814669. [PMID: 35252093 DOI: 10.3389/fpubh.2022.814669] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Kopjar M, Buljeta I, Ćorković I, Pichler A, Šimunović J. Adsorption of Quercetin on Brown Rice and Almond Protein Matrices: Effect of Quercetin Concentration. Foods 2022;11:793. [DOI: 10.3390/foods11060793] [Reference Citation Analysis]
25 Scapaticci S, Neri CR, Marseglia GL, Staiano A, Chiarelli F, Verduci E. The impact of the COVID-19 pandemic on lifestyle behaviors in children and adolescents: an international overview. Ital J Pediatr 2022;48:22. [PMID: 35120570 DOI: 10.1186/s13052-022-01211-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
26 Kirkova D, Stremski Y, Statkova-abeghe S, Docheva M. Quercetin Hybrids—Synthesis, Spectral Characterization and Radical Scavenging Potential. Molbank 2022;2022:M1329. [DOI: 10.3390/m1329] [Reference Citation Analysis]
27 Evangelou K, Veroutis D, Paschalaki K, Foukas PG, Lagopati N, Dimitriou M, Papaspyropoulos A, Konda B, Hazapis O, Polyzou A, Havaki S, Kotsinas A, Kittas C, Tzioufas AG, de Leval L, Vassilakos D, Tsiodras S, Stripp BR, Papantonis A, Blandino G, Karakasiliotis I, Barnes PJ, Gorgoulis VG. Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis. Eur Respir J 2022:2102951. [PMID: 35086840 DOI: 10.1183/13993003.02951-2021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
28 Paul AK, Hossain MK, Mahboob T, Nissapatorn V, Wilairatana P, Jahan R, Jannat K, Bondhon TA, Hasan A, de Lourdes Pereira M, Rahmatullah M. Does Oxidative Stress Management Help Alleviation of COVID-19 Symptoms in Patients Experiencing Diabetes? Nutrients 2022;14:321. [PMID: 35057501 DOI: 10.3390/nu14020321] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
29 Shohan M, Nashibi R, Mahmoudian-Sani MR, Abolnezhadian F, Ghafourian M, Alavi SM, Sharhani A, Khodadadi A. The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial. Eur J Pharmacol 2022;914:174615. [PMID: 34863994 DOI: 10.1016/j.ejphar.2021.174615] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
30 Rondanelli M, Perna S, Gasparri C, Petrangolini G, Allegrini P, Cavioni A, Faliva MA, Mansueto F, Patelli Z, Peroni G, Tartara A, Riva A. Promising Effects of 3-Month Period of Quercetin Phytosome® Supplementation in the Prevention of Symptomatic COVID-19 Disease in Healthcare Workers: A Pilot Study. Life (Basel) 2022;12:66. [PMID: 35054459 DOI: 10.3390/life12010066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
31 van Eijk LE, Tami A, Hillebrands JL, den Dunnen WFA, de Borst MH, van der Voort PHJ, Bulthuis MLC, Veloo ACM, Wold KI, Vincenti González MF, van der Gun BTF, van Goor H, Bourgonje AR. Mild Coronavirus Disease 2019 (COVID-19) Is Marked by Systemic Oxidative Stress: A Pilot Study. Antioxidants (Basel) 2021;10:2022. [PMID: 34943125 DOI: 10.3390/antiox10122022] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
32 Wang S, Yao X, Ma S, Ping Y, Fan Y, Sun S, He Z, Shi Y, Sun L, Xiao S, Song M, Cai J, Li J, Tang R, Zhao L, Wang C, Wang Q, Zhao L, Hu H, Liu X, Sun G, Chen L, Pan G, Chen H, Li Q, Zhang P, Xu Y, Feng H, Zhao GG, Wen T, Yang Y, Huang X, Li W, Liu Z, Wang H, Wu H, Hu B, Ren Y, Zhou Q, Qu J, Zhang W, Liu GH, Bian XW. A single-cell transcriptomic landscape of the lungs of patients with COVID-19. Nat Cell Biol 2021;23:1314-28. [PMID: 34876692 DOI: 10.1038/s41556-021-00796-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 19.0] [Reference Citation Analysis]
33 Lynch SM, Guo G, Gibson DS, Bjourson AJ, Rai TS. Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease. Cells 2021;10:3367. [PMID: 34943875 DOI: 10.3390/cells10123367] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
34 Pandolfi S, Chirumbolo S, Ricevuti G, Valdenassi L, Bjørklund G, Lysiuk R, Doşa MD, Lenchyk L, Fazio S. Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal. Basic Clin Pharmacol Toxicol 2021. [PMID: 34811895 DOI: 10.1111/bcpt.13690] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
35 Li G, De Oliveira DMP, Walker MJ. The antimicrobial and immunomodulatory effects of Ionophores for the treatment of human infection. J Inorg Biochem 2021;227:111661. [PMID: 34896767 DOI: 10.1016/j.jinorgbio.2021.111661] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
36 Asili P, Mirahmad M, Tabatabaei-Malazy O, Manayi A, Haghighat E, Mahdavi M, Larijani B. Characteristics of published/registered clinical trials on COVID-19 treatment: A systematic review. Daru 2021;29:449-67. [PMID: 34762250 DOI: 10.1007/s40199-021-00422-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Prutskij T, Deriabina A, Melendez FJ, Castro ME, Castillo Trejo L, Vazquez Leon GD, Gonzalez E, Perova TS. Concentration-Dependent Fluorescence Emission of Quercetin. Chemosensors 2021;9:315. [DOI: 10.3390/chemosensors9110315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Ciardi M, Ianni F, Sardella R, Di Bona S, Cossignani L, Germani R, Tiecco M, Clementi C. Effective and Selective Extraction of Quercetin from Onion (Allium cepa L.) Skin Waste Using Water Dilutions of Acid-Based Deep Eutectic Solvents. Materials (Basel) 2021;14:6465. [PMID: 34771995 DOI: 10.3390/ma14216465] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Asif M, Saleem M, Yaseen HS, Yehya AH, Saadullah M, Zubair HM, Oon CE, Khaniabadi PM, Khalid SH, Khan IU, Mahrukh. Potential role of marine species-derived bioactive agents in the management of SARS-CoV-2 infection. Future Microbiol 2021;16:1289-301. [PMID: 34689597 DOI: 10.2217/fmb-2021-0024] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Saied EM, El-Maradny YA, Osman AA, Darwish AMG, Abo Nahas HH, Niedbała G, Piekutowska M, Abdel-Rahman MA, Balbool BA, Abdel-Azeem AM. A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19. Pharmaceutics 2021;13:1759. [PMID: 34834174 DOI: 10.3390/pharmaceutics13111759] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
41 Manjunath SH, Thimmulappa RK. Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19. J Pharm Anal 2021. [PMID: 34567823 DOI: 10.1016/j.jpha.2021.09.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
42 Boretti A. Quercetin Supplementation and COVID-19. Natural Product Communications 2021;16:1934578X2110427. [DOI: 10.1177/1934578x211042763] [Reference Citation Analysis]
43 Lee S, Yu Y, Trimpert J, Benthani F, Mairhofer M, Richter-Pechanska P, Wyler E, Belenki D, Kaltenbrunner S, Pammer M, Kausche L, Firsching TC, Dietert K, Schotsaert M, Martínez-Romero C, Singh G, Kunz S, Niemeyer D, Ghanem R, Salzer HJF, Paar C, Mülleder M, Uccellini M, Michaelis EG, Khan A, Lau A, Schönlein M, Habringer A, Tomasits J, Adler JM, Kimeswenger S, Gruber AD, Hoetzenecker W, Steinkellner H, Purfürst B, Motz R, Di Pierro F, Lamprecht B, Osterrieder N, Landthaler M, Drosten C, García-Sastre A, Langer R, Ralser M, Eils R, Reimann M, Fan DNY, Schmitt CA. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature 2021. [PMID: 34517409 DOI: 10.1038/s41586-021-03995-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]